Trial Profile
Phase III trial investigating the efficacy of nelotanserin in patients with insomnia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Nelotanserin (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- 16 Oct 2007 New trial record.